About Us

Our Approach

The strategy of beauty care can be a real head scratcher, but our team of experts can help. Our in-depth experience in beauty care solutions, fully encompasses all theaters of research and development, including academia, industry, and government programs.  We are proven communicators and have the ability to translate complex ideas and concepts into understandable terminology, while creating engaging presentations that lead and inspire.

Our strategic planning strategy is based on science, using the creation of hypotheses and the careful generation of tests.  We’ll create strategic programs to bring innovative beauty care products to market.

75-2

Dr. Thomas Dawson, Jr.

CEO  |  Owner

Meet the Scientist

Thomas Dawson is a global leader in the development and execution of beauty care solutions, with a proven track record of creating strategic programs which bring innovative products to market. He is successful at attracting world class talent, melding them into high-functioning teams, and leading them to realize project objectives.  With over 30 years of experience in identification and commercialization of bio-active treatments, Thomas Dawson has earned an impressive list of accomplishments, including:

  • 2015-Present, Leader, Hair and Skin Health Platform Development, Agency for Science, Technology, and Research, Institute of Medical Biology, Singapore
  • 2012-2015, P&G, strategic leader of Life Sciences in new Singapore Innovation Center (SgIC)
  • 2006-2012, P&G, identification of a novel consumer benefit, patentable technology, and new market entry, Pantene Age Defy Thickening serum, at $200 mil/year incremental
  • 1998-2006, P&G, discovery of cause of dandruff, development of current in-bottle H&S formulation, and design and execution of winning IP and external credentialing strategy, growing H&S from a $0.7 to a $2.5 billion dollar brand
  • 1994-98, again UNC-Chapel Hill, Lineberger Comprehensive Cancer Center, discovery and patenting of a novel tyrosine kinase, the beginning of an anti-cancer SME and a series of anti-cancer drugs
  • 1989, UNC Chapel Hill, Cell Biology and Anatomy, developed “Carolina Rinse” Solution